NATIONAL BOSTON MEDICAL INC
4, 2000-02-10
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: PNC MORTGAGE SECURITIES CORP MORT PASS THRO CERT SER 1999-5, 8-K, 2000-02-10
Next: PNC MORTGAGE SEC CORP MORT PASS THR CERT SER 1999-7, 8-K, 2000-02-10




                                     FORM 4
OMB Approval
OMB Number 3235-0362
Expires: February 1, 1994

                                      U.S. SECURITIES AND EXCHANGE COMMISSION
                                              WASHINGTON, D.C. 20549

                                   STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the securities  Exchange Act of 1934, Section
17(a) of the Public Utility  Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940

__   Check if no longer subject to Section 16, Form 4 or Form 5,  Obligation may
     continue. (See Instructions)

<TABLE>
<S>                                                         <C>
1. Name and Address of Reporting Person:                    Bianchi, Vittorio
                                                            43 Taunton Green, 3rd Floor
                                                            Taunton, MA 02780
2. Issuer Name and Ticker or Trading Symbol:                National Boston Medical, Inc.
                                                            "NBMXE"
3. IRS or SSN of Reporting Person (Voluntary):              N/A
4. Statement for Month/Year                                 1/2000
5. If Amendment, Date of Original:
6. Relation of Reporting Person to Issuer                   X Director
                                                            _ 10% owner
                                                            X Officer (Title):
                                                            _ Other (Specify)
     X Filed by One Reporting Person.
     _ Filed by more than One Reporting Person.
</TABLE>


TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED

<TABLE>
<S>                                     <C>                       <C>                        <C>
1. Title of Security:                   Common Stock              Common Stock               Common Stock
2. Transaction Date:                                              1/00
3. Transaction Code                                               S
4. Securities Acquired (A) or
   Disposed (D):   Amount:                                        279,000
   A or D:                                                        D
   Price:                                                         $27,610
5. Amount of Securities                 120,000                   853,500                    100,000
   Beneficially owned at end
   of Month:
6. Ownership Form:                      D                         I                          I
   Direct (D) or Indirect (I):
7. Nature of Indirect                                             Joint w/ Spouse            Trust
   Beneficial Ownership:
</TABLE>

*If the form is filed by more than one Reporting Person, see instruction 5(b)(v)
Reminder:  Report on a separate Line for each class of  securities  beneficially
owned directly or indirectly.



<PAGE>


FORM 4 (continued)


TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED
1.  Title of Derivative Security:
2.  Conversion or Exercise Price of Derivative Security:
3.  Transaction Date (M/D/Y):
4.  Transaction Code:
            V:
5.  Number of Derivative Securities Acquired (A) or Disposed of (D):
6.  Date Exercisable:
     Expiration Date:
7.  Title of Underlying Securities:
Amount or number of Shares:
8.  Price of Derivative Security:
9.  Number of Derivative Securities Beneficially Owned  at end of Month:
10. Ownership of Derivative Securities;
    (D) Direct or (I) Indirect:
11. Nature of Indirect Beneficial Ownership:

EXPLANATION OF RESPONSES:







/s/ Vittorio Bianchi                            Date: 2/10/00
- ----------------------------
Vittorio Bianchi
**Signature of Reporting Person
**Intentional  misstatements or omissions of facts  constitute  Federal Criminal
Violations. See Sections 18 U.S.C. 1001, 15 U.S.C. 78ff(a).





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission